
Sartorius AG
Sartorius AG is a Germany-based company in the Healthcare sector with a market capitalisation of $20.3B. Its FinScore is 58/100; its highest-scoring layer is Momentum (73) and its lowest is Value (41). The shares trade at 105.1x trailing earnings and are up 5% year to date.
Share price performance
About Sartorius AG
www.sartorius.comSartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. The company's diverse portfolio encompasses several critical areas: For biosensing and detection, it provides biosensors, compliance instruments, system software, label-free detection technologies, and SPR systems. In cell analysis, Sartorius offers live-cell analysis platforms, flow cytometry systems, and specialized cell analysis reagents and consumables. Its media and reagent segment includes a wide array of formulations for antibody and recombinant protein production, viral vaccines, regenerative medicine, and stem cell cultivation, along with downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. The company manufactures various bioreactor systems, from multi-parallel and benchtop units to single-use, stainless steel, cell culture, and microbial bioreactors, all supported by dedicated software applications. Its extensive filtration product line features membranes, blotting products, filter papers, and glass and quartz microfibre products, alongside a comprehensive range of filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, particle analysis, pharmaceutical applications, protein/DNA concentration, venting, clarification, and membrane chromatography. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and cutting-edge process analytical technology with data analytics. Complementary laboratory equipment includes industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond its products, Sartorius provides essential services such as bioprocess development and engineering, protein expression system optimization, media and process development, comprehensive testing, instrument support, and validation. These offerings primarily serve the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industrial sectors across the globe.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- HQ
- Germany
- Fiscal year-end
- December
- Trading currency
- EUR
- Reporting currency
- EUR
- Fundamentals updated
- 5 days ago
- Market cap
- $20.3B
- Shares outstanding
- 69.1M
- P/E (TTM)
- 105.1x
- Dividend yield (TTM)
- 0.36%
- Beta (issuer)
- 1.47
- Revenue (latest FY)
- €3.5B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Sartorius AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Sartorius AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Sartorius AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Sartorius AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Sartorius AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Sartorius AG is available to Finryse members. The Overview stays open to everyone; creating an account is free.